Navigation Links
Hill-Rom Reports Fiscal Fourth Quarter and Full Year Results; Provides 2012 Financial Outlook
Date:10/26/2011

" "projection," "forecast," "continue," "accelerate," "promise," "increase," "higher," "lower," "reduce," "improve," "expand," "progress," "potential" or the negative of those terms or other variations of them or by comparable terminology.  The absence of such terms, however, does not mean that the statement is not forward-looking.  It is important to note that forward-looking statements are not guarantees of future performance, and the Company's actual results could differ materially from those set forth in any forward-looking statements.  Factors that could cause actual results to differ from forward-looking statements include but are not limited to: the Company's dependence on its relationships with several large group purchasing organizations, whether the Company's new products are successful in the marketplace, impacts of healthcare reform, compliance with federal healthcare programs, collections of accounts receivable, compliance with FDA regulations, antitrust and other litigation, potential exposure to product liability or other claims, failure of the Company's announced or future strategic initiatives and restructuring and realignment activities to achieve expected growth, efficiencies or cost reductions, adverse consequences resulting from the spin-off of the funeral services business, failure of the Company to execute its acquisition and business alliance strategy through the consummation and successful integration of acquisitions or entry into joint ventures or other business alliances, increased costs or unavailability of raw materials, adverse changes in global economic conditions or disruptions of credit markets, labor disruptions, the ability to retain executive officers and other key personnel, and certain tax-related matters.  For a more in depth discussion of these and other factors that could cause actual results to differ from those contained in forward-looking statements, see the discussions under the heading "Risk Factors"
'/>"/>
SOURCE Hill-Rom Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Hill-Rom Announces Appointment of James R. Giertz to Board of Directors
2. Hill-Rom Announces Corporate Governance Enhancements
3. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 Fourth Quarter Earnings and 2010 Financial Guidance Webcast
4. Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter
5. Hill-Rom and Encompass Group Form Joint Venture
6. Hill-Rom to Host Investors Conference in New York City
7. Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies
8. Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings
9. Hill-Rom Introduces Smart Bed Technology into CareAssist(R) ES Bed
10. Hill-Rom to Present at the Canaccord Adams Musculoskeletal Conference
11. Hill-Rom Extends Smart Bed Features for High-Tech Hospital Rooms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... March 4, 2015   Mayo Clinic and ... develop the next generation of wearable biosensors designed to ... that this technology will be game-changer. These patch biosensors ... James Levine, M.D., Ph.D. , a Mayo Clinic ... inexpensive, and can be integrated into the care people ...
(Date:3/4/2015)... 4, 2015  Results of the recent study, ... MarginProbe for Intra-Operative Positive Margin Detection , were presented ... 32 nd Annual Miami Breast Cancer Conference last ... Moshe Papa , MD, FACS, Professor of Surgery at ... reports an analysis of MarginProbe,s efficiency and accuracy when ...
(Date:3/4/2015)...  Bayer HealthCare today announced that the U.S. ... company,s Biologics License Application (BLA) for BAY 81-8973, ... FDA approval of the investigational compound, proposed trade ... in children and adults. "Bayer ... hemophilia A patients who need them," said ...
Breaking Medicine Technology:Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 2Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 3New Study Shows Breast Re-excision Rates Significantly Reduced in 100 Consecutive Cases 2FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 2FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 3
... Jan. 3, 2012 Reportlinker.com announces that ... in its catalogue: Transdermal ... http://www.reportlinker.com/p0203552/Transdermal-Drug-Delivery---Technologies-Markets-and-Companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ... -Up-to-date one-stop information on transdermal ...
... 3, 2012  When the FDA removed Fen-Phen from the U.S. ... that powerful diet pills had become a thing of the ... burners sprung up almost immediately, and it wasn,t long before ... bags and medicine cabinets. Demand for these ...
Cached Medicine Technology:Transdermal Drug Delivery - Technologies, Markets, and Companies 2Transdermal Drug Delivery - Technologies, Markets, and Companies 3Transdermal Drug Delivery - Technologies, Markets, and Companies 4Transdermal Drug Delivery - Technologies, Markets, and Companies 5Transdermal Drug Delivery - Technologies, Markets, and Companies 6Transdermal Drug Delivery - Technologies, Markets, and Companies 7Transdermal Drug Delivery - Technologies, Markets, and Companies 8Transdermal Drug Delivery - Technologies, Markets, and Companies 9Transdermal Drug Delivery - Technologies, Markets, and Companies 10Transdermal Drug Delivery - Technologies, Markets, and Companies 11BiphedAdrene™, Complex Phenylethylamine Provisional Plus Aggressive Thermogenic Compound, Leads Super-Powerful "Diet Pill" Comeback 2
(Date:3/5/2015)... Brunswick (PRWEB) March 05, 2015 Elandas ... validate product innovations as the company prepares to announce ... be comprised of individuals in the Life Sciences field. ... with our clients,” said Elandas CEO Ryan Roberts. “We ... a successful organization through our collaborative efforts. As we ...
(Date:3/4/2015)... (PRWEB) March 05, 2015 The ... therapeutics landscape over the past decade. The pharmaceutical ... for drug delivery in the form of liposomes ... manifold drugs with more safety and efficiency. ... could perhaps rely greatly upon the enhanced permeability ...
(Date:3/4/2015)... March 04, 2015 Ultraman Florida is ... mile swim, 261.4 mile bike, and 52.4 mile run. ... time of 24:45:45. , "This race was awesome and ... wonderful team and sponsors for supporting me through every ... 2015 had a total of 40 select participants invited ...
(Date:3/4/2015)... TROY Healthcare Solutions will be introducing TROY Secure ... of security for prescriptions, in Houston, Texas on Wednesday, ... located at 6633 Travis Street from 7 AM to ... Healthcare Solutions will host a continental breakfast. Starting at ... each hour to introduce attendees to TROY Secure Print ...
(Date:3/4/2015)... York, NY (PRWEB) March 04, 2015 ... creative, breakthrough marketing campaign called 'We Love Smokers' from ... cravings for tobacco. , "It’s important to establish ... be true to it. Our idea, 'We Love Smokers' ... leadership point of view. We created a bold tone ...
Breaking Medicine News(10 mins):Health News:Elandas Creates Advisory Board to Help Guide Innovation 2Health News:Cancer Nanomedicine Marketplace Discussed by Kuick Research in Topical Study Recently Published at MarketPublishers.com 2Health News:Cancer Nanomedicine Marketplace Discussed by Kuick Research in Topical Study Recently Published at MarketPublishers.com 3Health News:Living Fuel Champion Christian Isakson Finishes Second In UltraMan Florida Test of Endurance 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 3Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 2Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 3
... to develop a microchip sensitive enough to quickly determine ... that the disease can be detected earlier for more ... in Nature Nanotechnology heralds an era when ... innovation is an indication that the age of nanomedicine ...
... September 28, 2009 NovoCure, Ltd., a privately held ... a non-invasive portable medical device for the treatment of ... today. Key investors in this round included Pfizer Inc, ... "We are very pleased that Pfizer, Johnson & Johnson ...
... poll by the Harvard School of Public Health and The Boston ... state,s health reform legislation, which was enacted in 2006, support it. ... 13% are not sure. The level of public support for the ... they support the law in 2008 to 59% in the current ...
... CA On October 2nd, 2009, Henry Gabelnick PhD, ... prestigious Alan F. Guttmacher lecture at the 2009 ... Los Angeles, California. Reproductive Health 2009 is a ... Planned Parenthood Federation of America National Medical Committee, and ...
... ... recently named to the advisory board for PerfectServe, a healthcare communications company. , ... Knoxville, Tenn. (PRWEB) September ... PerfectServe , a healthcare communications company. The board provides guidance on innovative ways to ...
... ... Research , ... September 28, 2009 -- Axiom Accelerated Patient Recruitment (Axiom), one of the ... messaging (SMS) services. , , , , ,"Mobile device outreach is the future of ...
Cached Medicine News:Health News:U of T researchers create microchip that can detect type and severity of cancer 2Health News:NovoCure Ltd. announces closing of financing round 2Health News:59 percent support Massachusetts' Landmark 2006 health reform law 2Health News:59 percent support Massachusetts' Landmark 2006 health reform law 3Health News:CONRAD executive director to give Guttmacher lecture at Reproductive Health 2009 2Health News:William Fuchs Named to PerfectServe Advisory Board 2Health News:Axiom Accelerated Patient Recruitment Rolls Out 2
... charts incorporate the slight change in the ... Sloan letters derived from the best corrected ... the ETDRS study. The original charts difficulty ... 234 eyes. In addition to the revised ...
... Cube is used to diagnose Stereo and Binocular ... of polarized glasses. The test can be ... visual attention, form and depth perception. The Stereo ... 450 seconds of arc and is ideal for ...
... "natural" Stereotest consists of three test plates(6mm, 3mm, ... in a range of 600 - 15 seconds. ... can only be detected if stereopsis is present. ... risk of the patient learning the correct answer. ...
Lumicon 48 mm red filter....
Medicine Products: